Closurefast radiofrequency ablation for the treatment of GSV: … · CEAP at 36 months Overall...

13
Closurefast radiofrequency ablation for the treatment of GSV: Technique and outcome results Stephen Black Consultant Vascular Surgeon Clinical Lead for Venous and Lymphoedema Surgery Guy’s and St Thomas’ Hospital London

Transcript of Closurefast radiofrequency ablation for the treatment of GSV: … · CEAP at 36 months Overall...

Page 1: Closurefast radiofrequency ablation for the treatment of GSV: … · CEAP at 36 months Overall 74.1% (189 limbs) showed an improvement when compared to pre-treatment (P< .001) C3

Closurefast radiofrequency ablation for the treatment of GSV: Technique and outcome results

Stephen Black Consultant Vascular Surgeon

Clinical Lead for Venous and Lymphoedema Surgery Guy’s and St Thomas’ Hospital London

Page 2: Closurefast radiofrequency ablation for the treatment of GSV: … · CEAP at 36 months Overall 74.1% (189 limbs) showed an improvement when compared to pre-treatment (P< .001) C3

Disclosure

Speaker name:

Stephen Black

I have the following potential conflicts of interest to report:

Consulting : Medtronic, Cook, Optimed, Volcano, Veniti

Employment in industry

Stockholder of a healthcare company

Owner of a healthcare company

Other(s)

I do not have any potential conflict of interest

Page 3: Closurefast radiofrequency ablation for the treatment of GSV: … · CEAP at 36 months Overall 74.1% (189 limbs) showed an improvement when compared to pre-treatment (P< .001) C3

System Components: ClosureFast Catheter

!  3 catheter sections: !  Handle !  Shaft !  Heating element

2. Shaft

Page 4: Closurefast radiofrequency ablation for the treatment of GSV: … · CEAP at 36 months Overall 74.1% (189 limbs) showed an improvement when compared to pre-treatment (P< .001) C3

Heating Element

Lubricious outer jacket covers heating element and thermocouple

Thermocouple

Page 5: Closurefast radiofrequency ablation for the treatment of GSV: … · CEAP at 36 months Overall 74.1% (189 limbs) showed an improvement when compared to pre-treatment (P< .001) C3

Closurefast™ Treatment Parameter Overview

!  20-second treatment cycles !  Generator timer counts down from 20 to 0 !  Energy delivery automatically stops at end of

cycle

!  Device temperature: 120°C !  Maximum power: 40 Watts

!  Impedance monitored internally by generator !  Indicate uniformity of heating along coli !  User prompted to make adjustments to

external compression if necessary

Page 6: Closurefast radiofrequency ablation for the treatment of GSV: … · CEAP at 36 months Overall 74.1% (189 limbs) showed an improvement when compared to pre-treatment (P< .001) C3

ClosureFast ablation - Method of Action

!  Vein wall heated via

!  RF energy delivery to catheter heating element, resulting in: !  Endothelial denaturation !  Collagen contraction !  Fibrotic sealing

Page 7: Closurefast radiofrequency ablation for the treatment of GSV: … · CEAP at 36 months Overall 74.1% (189 limbs) showed an improvement when compared to pre-treatment (P< .001) C3

Covidien | Februar 2, 2016 | Confidential 7 |

ClosureFast segmental ablation procedure

Page 8: Closurefast radiofrequency ablation for the treatment of GSV: … · CEAP at 36 months Overall 74.1% (189 limbs) showed an improvement when compared to pre-treatment (P< .001) C3

Covidien | Februar 2, 2016 | Confidential 8 |

ClosureFast full vessel wall fibrosis induction

Goat saphenous vein 12 wks post-ablation

Page 9: Closurefast radiofrequency ablation for the treatment of GSV: … · CEAP at 36 months Overall 74.1% (189 limbs) showed an improvement when compared to pre-treatment (P< .001) C3

EVLA vs. ClosureFast: Continuous Pullback vs. Segmental Ablation

Endovenous Laser Ablation

Continuous Pullback !  Used by endovenous lasers and some RF

ablation systems (F-Care Systems) !  Energy source is on throughout treatment !  Energy delivery varies by pullback speed

as well as other factors !  Small area treated at any given time

ClosureFast™ Catheter

Segmental Ablation !  Used by the VenefitTM procedure

delivered by the ClosureFastTM catheter

!  Vein segment treated at one time !  No energy delivered during catheter

pullback !  Energy delivery does not vary by pullback

speed

Image source: Covidien R&D dept.

Page 10: Closurefast radiofrequency ablation for the treatment of GSV: … · CEAP at 36 months Overall 74.1% (189 limbs) showed an improvement when compared to pre-treatment (P< .001) C3

Title: Randomized clinical trial comparing endovenous laser ablation, radiofrequency ablation, foam sclerotherapy, and surgical stripping for great saphenous varicose veins with 3 year follow up. Author: Rasmussen L, Lawaetz M, Serup J et al. Journal: Journal of Vascular Surgery: Venous and Lymphatic Disorders; published online August 5, 2013

•  RESULTS •  500 patients (580 limbs) were randomized. All groups were similar in regards to baseline

characteristics.

•  Kaplan Meier estimates – showing the percent of patients who were free from the following endpoints at 3 yrs *P<.0001 difference across all 4 groups

RFA EVLA UGFS Stripping Reflux-free* 93% 93.2% 73.6% 93.5% Free of Recurrent Varicose Veins

85.1% 80% 80.9% 79.8%

Free of Reoperations*

88.9% 87.5% 68.4% 84.5%

CONCLUSIONS The author concluded that all treatment modalities were efficacious and resulted in a similar improvement in VCSS and QOL. However, more recanalization and reoperations were seen after UGFS

Page 11: Closurefast radiofrequency ablation for the treatment of GSV: … · CEAP at 36 months Overall 74.1% (189 limbs) showed an improvement when compared to pre-treatment (P< .001) C3

CEAP at 36 months

Overall 74.1% (189 limbs) showed an improvement when compared to pre-treatment (P< .001)

C3 & C4 8%, a reduction from 46% at pre-treatment

C4 (skin changes) 4%, a reduction from 15% at pre-treatment

C2 33.3% an increase from 12.5% at 12 months This may be due to the normal course of the disease or related to the study protocol prohibiting the treatment of thigh varicosities

Secondary Endpoints: CEAP and VCSS

Title: The 5-year Final Results from the Prospective European Multicentre Cohort Study on Radiofrequency Segmental Thermal Ablation of Incompetent Great Saphenous Veins Authors: Proebstle TM, Alm BJ, Göckeritz O, Wenzel C, Noppeney T, Lebard C, Sessa C, Creton D, Pichot O Journal: British Journal of Surgery 2015

VCSS at 60 months

Pre-treatment 3.9 ± 2.1

3-60 months 1.3 ± 1.7; P<0.0001

295 limbs enrolled

3 Months 6 Months 1 year 2 Year 3 Year 5 Year 235 limbs @

5 yr f/u

Vein Occlusion 99.7% 98.6% 96.3% 94.5% 92.6% 91.9%

No Reflux 99.7% 99.3% 99.0% 97.2% 95.7% 94.9%

Page 12: Closurefast radiofrequency ablation for the treatment of GSV: … · CEAP at 36 months Overall 74.1% (189 limbs) showed an improvement when compared to pre-treatment (P< .001) C3

Conclusion

•  Safe and effective treatment •  Straightforward •  Good long term data •  May be challenged by the NTNT

techniques

Page 13: Closurefast radiofrequency ablation for the treatment of GSV: … · CEAP at 36 months Overall 74.1% (189 limbs) showed an improvement when compared to pre-treatment (P< .001) C3

Closurefast radiofrequency ablation for the treatment of GSV: Technique and outcome results

Stephen Black Consultant Vascular Surgeon

Clinical Lead for Venous and Lymphoedema Surgery Guy’s and St Thomas’ Hospital London